Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

被引：0
|
作者：
Hsu, Connie [1 ]
Snyder, Robert [2 ]
Clore, Lee [3 ]
Jain, Vipul [4 ]
Gimenez-Arnau, Ana [5 ]
Lheritier, Karine [6 ]
Walsh, Pauline [7 ]
Haemmerle, Sibylle [6 ]
Wells, Michael [8 ]
Nikolaev, Ivan [6 ]
Maurer, Marcus [9 ,10 ,11 ,12 ]
机构：
[1] Res Solut Arizona, Phoenix, AZ USA
[2] Riverchase Dermatol, Pembroke Pines, FL USA
[3] Allergy & Asthma Specialists PSC, Owensboro, KY USA
[4] McMaster Univ, Div Clin Immunol & Allergy, Dept Med, Hamilton, ON, Canada
[5] Univ Pompeu Fabra, Hosp Mar IMIM, Dept Dermatol, Barcelona, Spain
[6] Novartis Pharma AG, Basel, Switzerland
[7] Novartis Ireland Ltd, Dublin, Ireland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Charit Univ Med Berlin, Inst Allergol, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany
[10] Free Univ Berlin, Berlin, Germany
[11] Humboldt Univ, Berlin, Germany
[12] Fraunhofer Inst Translatio, Frankfurt, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42939
引用
收藏
页码：AB82 / AB82
页数：1
相关论文
共 50 条
  • [41] Accompanying conditions in patients with chronic spontaneous urticaria and urticarial vasculitis: Results of a retrospective study
    Akarsu, Sevgi
    Ilknur, Turna
    Ozbagcivan, Ozlem
    Fetil, Emel
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2015, 49 (01): : 18 - 24
  • [42] Time to Onset of Linaclotide Effect On the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2B Study
    Johnston, Jeffrey M.
    Lavins, Bernard J.
    MacDougall, James E.
    Lembo, Anthony J.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A537 - A537
  • [43] Association of pruritus with sleep in patients with psoriasis and chronic spontaneous urticaria: A cross-sectional study
    Shukla, Prakriti
    Verma, Parul
    Tripathi, Srishti
    Dwivedi, Alok K.
    Shukla, Mukesh
    Suvirya, Swastika
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (09) : 1908 - 1916
  • [44] Study design and rationale of a phase 3b extension study of ligelizumab in adult and adolescent patients with chronic spontaneous urticaria
    Severin, T.
    Maurer, M.
    Gimenez-Arnau, A. M.
    Hide, M.
    Sussman, G.
    Saini, S. S.
    Hua, E.
    Barve, A.
    Joubert, Y.
    Indermuehle, I.
    Janocha, R.
    ALLERGY, 2020, 75 : 446 - 447
  • [45] Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study
    Berard, F.
    Le Bouedec, M. C. Ferrier
    Bouillet, L.
    Reguiai, Z.
    Barbaud, A.
    Cambazard, F.
    Milpied, B.
    Pelvet, B.
    Kasujee, I.
    Gharbi, H.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 56 - 66
  • [46] Patients' Experience of Parkinson's Disease Following Treatment with Inhaled Levodopa: Results from a Phase 2b Study
    LeWitt, Peter
    Niyazov, Alexander
    Sedkov, Alexander
    Murck, Harald
    Guo, Amy
    NEUROLOGY, 2016, 86
  • [47] ARS-2, Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study Results
    Bernstein, David
    Talreja, Neetu
    Casale, Thomas
    Li, H. Henry
    Shreffler, Wayne
    Lowenthal, Richard
    Tanimoto, Sarina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB255 - AB255
  • [48] Setrusumab for the Treatment of Osteogenesis Imperfecta (OI): Results from the Phase 2b ASTEROID Study
    Glorieux, Francis
    Javaid, Muhammad K.
    Langdahl, Bente
    Chapurlat, Roland
    De Beur, Suzanne Jan
    Sutton, V. Reid
    Poole, Kenneth
    Orwoll, Eric S.
    Willie, Bettina
    Mikolajewicz, Nicholas
    Clancy, James
    MacKinnon, Alastair
    Mistry, Arun
    Ominsky, Michael S.
    Saville, Chris
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 5 - 6
  • [49] Safety and tolerability of omalizumab in patients with chronic idiopathic/spontaneous urticaria: Results from the OPTIMA study
    Sussman, Gordon
    Hebert, Jacques
    Gooderham, Melinda
    Gulliver, Wayne
    Lynde, Charles W.
    Papp, Kim A.
    Yang, William H.
    de Takacsy, Frederica
    Chambenoit, Olivier
    Rihakova, Lenka
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB250 - AB250
  • [50] Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
    F Maloisel
    A Guerci
    D Guyotat
    N Ifrah
    M Michallet
    J Reiffers
    G Tertain
    M Blanc
    F Bauduer
    J Brière
    JF Abgrall
    B Pegourie-Bandelier
    E Solary
    N Cambier
    D Coso
    JP Vilque
    M Delain
    JL Harousseau
    P Rousselot
    K Belhadj
    P Morice
    J Attal
    M Chabin
    C Chastang
    J Guilhot
    F Guilhot
    Leukemia, 2002, 16 : 573 - 580
12345